MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
QNCX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Quince Therapeutics (QNCX) Ownership - Who owns Quince Therapeutics?

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
38
Web
https://www.quincetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.14M
P/E Ratio
N/A
Total Cash
18.16M
Projected Growth
N/A
Total Debt
406K
Revenue
N/A
Risk (Beta)
0.76
Dividend Yield
N/A
Total Cash/Share
0.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
QNCX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for QNCX
A.I. Advisor
published General Information

General Information

a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
38
Web
https://www.quincetx.com